ADME 毒理學測試市場規模、佔有率和成長分析（按方法、技術、應用、最終用戶和地區）- 產業預測 2025-2032

2023 年 ADME 毒理學測試市場規模價值 104 億美元，預計將從 2024 年的 116.5 億美元成長到 2032 年的 288.4 億美元，預測期內（2025-2032 年）的複合年成長率為 12.0%。

ADME 毒性測試市場在評估物質的藥物動力學和藥物動力學方面發揮著至關重要的作用，這對於藥物開發和安全性評估至關重要。隨著製藥公司轉向這些測試以滿足嚴格的監管要求並確保患者安全，對更安全、更有效藥物的需求正在推動市場成長。儘管市場動態強勁，但挑戰仍然存在，包括人體生理的複雜性、成本限制和不斷變化的監管準則。然而，體外和電腦測試方法的進步以及個人化醫療的興起也帶來了光明的機會。在技​​術創新和法規遵循的推動下，美國ADME 毒性測試市場預計將在未來預測期內持續成長。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

ADME 毒性測試市場規模（按方法和複合年成長率） (2025-2032)

• 市場概況
• 細胞檢測
• 生化分析
• 二氧化矽
• 體外

ADME 毒性測試市場規模（依技術及複合年成長率） (2025-2032)

• 市場概況
• 細胞培養
• 高吞吐量
• 分子影像
• 體學技術

ADME 毒性測試市場規模（按應用分類）及複合年成長率（2025-2032）

• 市場概況
• 全身毒性
• 腎毒性
• 肝毒性
• 神經毒性
• 其他

ADME 毒性測試市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 醫院和診所
• 診斷中心
• 病理實驗室
• 其他

ADME 毒性測試市場規模（按地區分類）及複合年成長率（2025-2032 年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Charles River Laboratories（USA）
• Eurofins Scientific（Luxembourg）
• WuXi AppTec（China）
• SGS SA（Switzerland）
• PPD（USA）
• Covance Inc.（USA）
• ICON plc（Ireland）
• LabCorp（USA）
• Syneos Health（USA）
• IQVIA（USA）
• Boehringer Ingelheim（Germany）
• Merck & Co.（USA）
• Pfizer Inc.（USA）
• Novartis AG（Switzerland）
• AstraZeneca（UK）
• GlaxoSmithKline plc（UK）
• Sanofi（France）
• Johnson & Johnson（USA）
• AbbVie Inc.（USA）
• Eli Lilly and Company（USA）

結論和建議

ADME Toxicology Testing Market size was valued at USD 10.4 billion in 2023 and is poised to grow from USD 11.65 billion in 2024 to USD 28.84 billion by 2032, growing at a CAGR of 12.0% during the forecast period (2025-2032).

The ADME toxicology testing market plays a crucial role in evaluating the pharmacokinetics and toxicokinetics of substances, critical for drug development and safety assessments. Demand for safer and more effective drugs drives market growth, as pharmaceutical companies lean on these tests to meet stringent regulatory requirements and ensure patient safety. Despite the robust market dynamics, challenges such as human physiological complexities, cost constraints, and evolving regulatory guidelines persist. However, there are promising opportunities in advancements in in vitro and in silico testing methods, as well as the rise of personalized medicine. The US ADME Toxicology Testing Market is projected to experience sustainable growth over the next forecast period, indicating a solid trajectory driven by innovation and regulatory compliance.

Top-down and bottom-up approaches were used to estimate and validate the size of the Adme Toxicology Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Adme Toxicology Testing Market Segments Analysis

Global ADME Toxicology Testing Market is segmented by Method, Technology, Application, End Users and region. Based on Method, the market is segmented into Cellular Assay, Biochemical Assay, In Silica and Ex-vivo. Based on Technology, the market is segmented into Cell Culture, High Throughput, Molecular Imaging and OMICS Technology. Based on Application, the market is segmented into Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Others. Based on End Users, the market is segmented into Hospitals and clinics, Diagnostic centers, Pathological Labs and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Adme Toxicology Testing Market

In 2022, the pharmaceutical sector saw a significant increase in drug development activities, spurred by the demand for novel therapeutics targeting various health conditions. This intensification in drug discovery and development significantly propelled the ADME toxicology testing market. Pharmaceutical companies and research institutions relied heavily on toxicology assessments to evaluate the safety and effectiveness of their drug candidates, ensuring rigorous safety protocols before moving forward with clinical trials and eventual market entry. Consequently, the heightened emphasis on innovative drug solutions has fostered substantial growth in the ADME toxicology testing market, underscoring its critical role in the drug development process.

Restraints in the Adme Toxicology Testing Market

The ADME Toxicology Testing market faces notable restraints primarily due to the substantial costs involved in various experimental processes, specialized equipment, and the need for skilled personnel. In 2022, these financial burdens significantly impacted the market's growth potential, especially for small to medium-sized pharmaceutical companies operating with constrained budgets. The high expenses associated with ADME toxicology testing can deter investment and limit opportunities for innovation among these smaller firms, ultimately slowing the overall advancement and expansion of the market. Thus, the financial implications remain a critical barrier to growth within this sector, necessitating strategic solutions to mitigate these challenges.

Market Trends of the Adme Toxicology Testing Market

The Adme Toxicology Testing market is experiencing a significant shift towards in vitro and in silico testing advancements, which gained substantial traction in 2022. These innovative methodologies provide cost-effective, efficient, and ethical alternatives to traditional animal testing, propelling the industry toward more humane practices. The growing emphasis on regulatory compliance and risk assessment has catalyzed the development of sophisticated in vitro assays and predictive modeling techniques, enhancing the accuracy and reliability of toxicology evaluations. As stakeholders increasingly prioritize sustainability and ethical considerations, the market is poised for sustained growth, driven by the continued integration of cutting-edge technologies in toxicological assessments.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global ADME Toxicology Testing Market Size by Method & CAGR (2025-2032)

• Market Overview
• Cellular Assay
• Biochemical Assay
• In Silica
• Ex-vivo

Global ADME Toxicology Testing Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Cell Culture
• High Throughput
• Molecular Imaging
• OMICS Technology

Global ADME Toxicology Testing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Systemic Toxicity
• Renal Toxicity
• Hepatotoxicity
• Neurotoxicity
• Others

Global ADME Toxicology Testing Market Size by End Users & CAGR (2025-2032)

• Market Overview
• Hospitals and clinics
• Diagnostic centers
• Pathological Labs
• Others

Global ADME Toxicology Testing Market Size & CAGR (2025-2032)

• North America (Method, Technology, Application, End Users)
  • US
  • Canada
• Europe (Method, Technology, Application, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Method, Technology, Application, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Method, Technology, Application, End Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Method, Technology, Application, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PPD (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covance Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LabCorp (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IQVIA (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations